833. Combined Manganese Superoxide Dismutase Gene Therapy and 5-FU Chemotherapy for Colorectal Cancer

Yanhong Zhang,Lingfeng He,Songqing He,Jian Wu,Xinyuan Liu

DOI: https://doi.org/10.1016/j.ymthe.2006.08.919

IF: 12.91

2006-01-01

Molecular Therapy

Abstract:BACKGROUND: Colorectal cancer (CRC) is one of the most common tumors worldwide, with approximately 1 million new cases diagnosed in 2000, and accounting for over 500,000 deaths. Novel agents that target specific molecular pathways are needed. A replication-competent adenoviral transduction of manganese superoxide dismutase (MnSOD) inhibited growth of colorectal tumor cells in culture and tumor xenografts in a mouse model (Cancer Research; 2006 in press). Fluorouracil (5-FU) is the most widely used anticancer agent for gastrointestinal cancers, and it is commonly used as adjuvant chemotherapy for colorectal cancer. The aim of this study is to assess the effect of MnSOD gene therapy combined with chemotherapy, on tumor growth and tumor-free survival. METHODS: Nude mice were divided into four groups: PBS control, ZD55-MnSOD injection, 5-FU injection, combined ZD55-MnSOD with 5-FU injection. 5-FU was administered intraperitoneally every other day after four times injection with ZD55-MnSOD. Cell cycles were assayed by FACS. DNA fragmentation, transition electronic microscope and TUNEL assay were used to determine the extent of apoptosis. RESULTS: There was a remarkable decrease in cell viability after colorectal tumor cells were treated with ZD55- MnSOD at various MOI and 5-FU from 24 hours to 72 hours. Enhanced apoptosis in tumor cells receiving the dual therapy was evident as determined by DNA fragmentation analysis, Hoechst 33258 staining, electron microcopy, and a TUNEL assay. Growth of tumor xenografts was significantly inhibited in nude mice 2 months after intratumoral injection of ZD55-MnSOD. The tumor volume decreased significantly in mice after receiving combined injection of ZD55-MnSOD and 5-FU, was much lower than that in mice receiving injections of ZD55-MnSOD or 5-FU alone (80.98±31.76 vs. 792.11±69.70, 1050±435.39 mm3). Moreover, the combined injection of ZD55-MnSOD with 5-FU markedly improved the animal survival, which was better than ZD55-MnSOD or 5-FU alone (66.7% vs. 50% and 33.3%). CONCLUSION: Both ZD55- MnSOD and 5-FU are shown to induce the apoptosis in colorectal tumor cells, while 5-FU potentiated the proapoptotic effect induced by ZD55-MnSOD. It appears that a caspase-dependent pathway is involved in the apoptotic onset in colorectal tumor cells caused by 5-FU or ZD55-MnSOD. Thus, dual adenoviral MnSOD gene therapy plus 5-FU chemotherapy achieved synergetic action in suppressing the tumor growth.